민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트
    34.
    发明公开
    민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 有权
    用于预测敏感性皮肤和测试套件的生物标记

    公开(公告)号:KR1020140123035A

    公开(公告)日:2014-10-21

    申请号:KR1020140124122

    申请日:2014-09-18

    CPC classification number: C12Q1/6844

    Abstract: Disclosed is a biomarker of which gene expression levels are specifically increased or reduced for sensitive skin. The biomarker specific to sensitive skin is used in such a diagnostic kit for sensitive skin and a screening method of an abirritant. The biomarker for diagnosis of sensitive skin according to the present invention includes one or more genes selected from a group consisting of HLA-C, TCEA1, IGHA1, TFRC, S100A8, LOC652128, SERPINB13, EHF, FLJ10781, TP63, CDH1, TNFRSF19, GM2A, FKBP5, PI3, PSPH, HORMAD1, SPRR2G, and ACTR2 or a group consisting of KBTBD10, TTN, ACTA1, MYBPC1, MB, MYOZ1, TPM1, CA3, CASQ1, ENO3, RBP4, GYG2, PPP1R1A, PYGM, G0S2, NEB, H19, LIPE, PLIN, H19, GPAM, FABP4, CIDEC, LPL, PCK1, ADIPOQ, PDE3B, ACVR1C, LPL, FABP4, DKFZP761N09121, TNMD, ATP6V1B1, C8orf22, and CRISP3.

    Abstract translation: 公开了一种生物标志物,其敏感性皮肤基因表达水平被特异地增加或降低。 敏感皮肤特异性的生物标志物用于敏感皮肤的诊断试剂盒和刺激物的筛选方法。 根据本发明的敏感性皮肤诊断用生物标志物包括选自HLA-C,TCEA1,IGHA1,TFRC,S100A8,LOC652128,SERPINB13,EHF,FLJ10781,TP63,CDH1,TNFRSF19,GM2A的一种或多种基因 ,FKBP5,PI3,PSPH,HORMAD1,SPRR2G和ACTR2或由KBTBD10,TTN,ACTA1,MYBPC1,MB,MYOZ1,TPM1,CA3,CASQ1,ENO3,RBP4,GYG2,PPP1R1A,PYGM,G0S2,NEB, H19,LIPE,PLIN,H19,GPAM,FABP4,CIDEC,LPL,PCK1,ADIPOQ,PDE3B,ACVR1C,LPL,FABP4,DKFZP761N09121,TNMD,ATP6V1B1,C8orf22和CRISP3。

    민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트
    35.
    发明公开
    민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 有权
    用于预测敏感性皮肤和测试套件的生物标记

    公开(公告)号:KR1020140123033A

    公开(公告)日:2014-10-21

    申请号:KR1020140124117

    申请日:2014-09-18

    CPC classification number: C12Q1/6844 C12Q1/6813

    Abstract: Disclosed is a biomarker of which gene expression levels are specifically increased or reduced for sensitive skin. The biomarker specific to sensitive skin is used in such a diagnostic kit for sensitive skin and a screening method of an abirritant. The biomarker for diagnosis of sensitive skin according to the present invention contains one or more gene selected from a group consisting of HLA-C, TCEA1, IGHA1, TFRC, S100A8, LOC652128, SERPINB13, EHF, FLJ10781, TP63, CDH1, TNFRSF19, GM2A, FKBP5, PI3, PSPH, HORMAD1, SPRR2G, and ACTR2 or a group consiting of KBTBD10, TTN, ACTA1, MYBPC1, MB, MYOZ1, TPM1, CA3, CASQ1, ENO3, RBP4, GYG2, PPP1R1A, PYGM, G0S2, NEB, H19, LIPE, PLIN, H19, GPAM, FABP4, CIDEC, LPL, PCK1, ADIPOQ, PDE3B, ACVR1C, LPL, FABP4, DKFZP761N09121, TNMD, ATP6V1B1, C8orf22, and CRISP3.

    Abstract translation: 公开了一种生物标志物,其敏感性皮肤基因表达水平被特异地增加或降低。 敏感皮肤特异性的生物标志物用于敏感皮肤的诊断试剂盒和刺激物的筛选方法。 根据本发明的敏感性皮肤诊断用生物标志物含有选自HLA-C,TCEA1,IGHA1,TFRC,S100A8,LOC652128,SERPINB13,EHF,FLJ10781,TP63,CDH1,TNFRSF19,GM2A ,FKBP5,PI3,PSPH,HORMAD1,SPRR2G和ACTR2或KBTBD10,TTN,ACTA1,MYBPC1,MB,MYOZ1,TPM1,CA3,CASQ1,ENO3,RBP4,GYG2,PPP1R1A,PYGM,G0S2,NEB, H19,LIPE,PLIN,H19,GPAM,FABP4,CIDEC,LPL,PCK1,ADIPOQ,PDE3B,ACVR1C,LPL,FABP4,DKFZP761N09121,TNMD,ATP6V1B1,C8orf22和CRISP3。

    민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트
    36.
    发明公开
    민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 有权
    用于预测敏感性皮肤和测试套件的生物标记

    公开(公告)号:KR1020140123031A

    公开(公告)日:2014-10-21

    申请号:KR1020140124110

    申请日:2014-09-18

    CPC classification number: C12Q1/6844 C12Q1/6813

    Abstract: 민감성 피부에 대해서 특이적으로 유전자 발현량이 증가 또는 억제되는 바이오 마커가 개시된다. 상기 민감성 피부에 특이적인 바이오 마커를 이용하여 민감성 피부 진단 키트 및 자극감 완화제의 스크리닝 방법 등에 활용할 수 있다.

    Abstract translation: 公开了具有针对敏感皮肤特异性增加或降低的基因表达量的生物标志物。 敏感皮肤特异性的生物标志物用于敏感皮肤的诊断试剂盒和刺激物的筛选方法。 根据本发明的敏感性皮肤诊断用生物标志物,选自HLA-C,TCEA1,IGHA1,TFRC,S100A8,LOC652128,SERPINB13,EHF,FLJ10781,TP63,CDH1,TNFRSF19,GM2A, FKBP5,PI3,PSPH,HORMAD1,SPRR2G和ACTR2或由KBTBD10,TTN,ACTA1,MYBPC1,MB,MYOZ1,TPM1,CA3,CASQ1,ENO3,RBP4,GYG2,PPP1R1A,PYGM,G0S2,NEB,H19组成的组 ,LIPE,PLIN,H19,GPAM,FABP4,CIDEC,LPL,PCK1,ADIPOQ,PDE3B,ACVR1C,LPL,FABP4,DKFZP761N09121,TNMD,ATP6V1B1,C8orf22和CRISP3。

    ETA를 함유하는 피부 외용제 조성물
    37.
    发明公开
    ETA를 함유하는 피부 외용제 조성물 无效
    包含(ALL-CIS)-11,14,17-EICOSATRIENOIC酸的皮肤外用应用组合物

    公开(公告)号:KR1020100120585A

    公开(公告)日:2010-11-16

    申请号:KR1020090039462

    申请日:2009-05-06

    Abstract: PURPOSE: A composition of external use skin formulation for anti-aging and moisturizing is provided to suppress MMP(matrix metalloprotease) increase. CONSTITUTION: A composition of external use skin formulation contains 0.001-10 weight% of 11,14,17-Eicosatrienoic acid(ETA) as an active ingredient. ETA is contained in oil phase. The composition is used for preventing aging through reduction of collagenase expression. The composition is also used for skin moisturizing by suppressing skin barrier damage.

    Abstract translation: 目的:提供抗老化和保湿的外用皮肤制剂组合物,以抑制MMP(基质金属蛋白酶)增加。 构成:外用皮肤制剂的组合物含有作为活性成分的11,14,17-二十碳三烯酸(ETA)的0.001-10重量%。 ETA含在油相中。 该组合物用于通过降低胶原酶表达来预防老化。 该组合物还可用于通过抑制皮肤屏障损伤来进行皮肤保湿。

Patent Agency Ranking